The up-regulation of both PRDX2 and PRDX6 is described in many tumors and correlated with invasiveness, migration, drug resistance and enhancing stem cell properties, in particular in NSCLC, colorectal cancer, and esophageal carcinoma [42–45]. The gene discussed is PRDX6; the disease is non-small cell lung carcinoma.